Production (Stage)
Immunome, Inc.
IMNM
$9.27
$0.141.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 317.32M | 217.30M | 240.13M | 278.35M | 309.71M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.81M | 4.04M | 3.91M | 5.93M | 3.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 323.13M | 221.34M | 244.04M | 284.28M | 313.33M |
|
|
|||||
| Total Current Assets | 323.13M | 221.34M | 244.04M | 284.28M | 313.33M |
| Net Property, Plant & Equipment | 15.12M | 14.39M | 9.56M | 8.62M | 5.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.45M | 4.51M | 3.30M | 3.31M | 668.00K |
| Total Assets | 342.69M | 240.24M | 256.90M | 296.22M | 319.75M |
|
|
|||||
| Total Accounts Payable | 9.13M | 14.19M | 3.52M | 7.05M | 7.18M |
| Total Accrued Expenses | 16.45M | 30.98M | 25.08M | 19.19M | 10.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 63.00K | 257.00K | 295.00K | 419.00K |
| Total Finance Division Other Current Liabilities | 5.23M | 9.08M | 10.67M | 13.37M | 12.80M |
| Total Other Current Liabilities | 5.23M | 9.08M | 10.67M | 13.37M | 12.80M |
| Total Current Liabilities | 30.80M | 54.31M | 39.53M | 39.90M | 30.77M |
|
|
|||||
| Total Current Liabilities | 30.80M | 54.31M | 39.53M | 39.90M | 30.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.77M | 4.77M | 2.46M | 2.48M | 1.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 4.77M | -- | -- | 2.21M |
| Total Liabilities | 35.57M | 59.08M | 41.99M | 42.38M | 34.18M |
|
|
|||||
| Common Stock & APIC | 864.54M | 696.88M | 650.36M | 642.26M | 637.87M |
| Retained Earnings | -557.41M | -515.77M | -435.52M | -388.42M | -352.30M |
| Treasury Stock & Other | -3.00K | 57.00K | 70.00K | 2.00K | 4.00K |
| Total Common Equity | 307.13M | 181.17M | 214.91M | 253.84M | 285.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 307.13M | 181.17M | 214.91M | 253.84M | 285.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 307.13M | 181.17M | 214.91M | 253.84M | 285.57M |
|
|
|||||